Treatment of HIV infection with a raltegravir-based regimen increases LDL levels, but improves HDL cholesterol efflux capacity

Nicholas T. Funderburg, Dihua Xu, Martin P. Playford, Aditya A. Joshi, Adriana Andrade, Daniel R. Kuritzkes, Michael M. Lederman, Nehal N. Mehta

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment of HIV infection with a raltegravir-based regimen increases LDL levels, but improves HDL cholesterol efflux capacity'. Together they form a unique fingerprint.

Medicine & Life Sciences